Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-12-02

Clinical Trial Update: BAY12-8039: 5 Days for Sinusitis vs Placebo [Phase 3]

View source ↗

Summary

Phase 3 trial by Bayer comparing BAY12-8039 to placebo for sinusitis has completed; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BAY12-8039

Snippet

Sponsor: Bayer | Conditions: Sinusitis | Phase 3 | Status: COMPLETED | Results posted: 2009-12-02